Email address
[email protected]Contact number
(415)772-1209Share profile
Band 3
Provided by Thomas E Duley
TOM DULEY has extensive experience representing life sciences companies in a wide range of technology and intellectual property transactions, including strategic collaborations, joint ventures, licenses, asset purchase and sale transactions and other commercial transactions. Tom brings problem-solving creativity and operational experience to clients ranging from startups to large public corporations. His experience also includes numerous cross-border transactions, including working with clients to develop and commercialize products in China. From 2006 to 2008, Tom was Senior Corporate Counsel at PDL Biopharma (NASDAQ: PDLI).
Tom was recognized in the 2022–2023 editions of Chambers USA in Life Sciences: Corporate/Commercial in California with clients noting, “Thomas is an excellent lawyer and an excellent advocate for his clients” (2022). He accepted the “Financial & Corporate Impact Deal of the Year” at the 2019 Legal Media Group (LMG) Life Sciences Awards for Sidley’s representation of Nurix Therapeutics in its collaboration with Gilead Sciences valued at US$2.48 billion; and the 2018 LMG Life Sciences Award for Financial & Corporate Attorney of the Year: Licensing & Collaboration.
Provided by Chambers
Thomas Duley is a respected transactional attorney who offers noteworthy expertise on collaboration and licensing agreements within the life sciences space.
Provided by Chambers
"Thomas immerses himself in the matter and ensures that our positions align with our strategic commercial goals."
"Thomas is extremely experienced and very smooth in negotiations. We highly value having him as a trusted partner."
"Thomas immerses himself in the matter and ensures that our positions align with our strategic commercial goals."
"Thomas is extremely experienced and very smooth in negotiations. We highly value having him as a trusted partner."
